Recently, scientific research has brought to light numerous benefits associated with the use of peppermint-based supplements. It is appreciated for its carminative and cholagogue properties, as well as its effectiveness in treating digestive disorders. Moreover, it is known for its qualities as an antineuralgic and decongestant.

However, one of the main obstacles in the use of this valuable herb is its predisposition to cause gastric irritation, especially when ingested in inadequately protected form.

In this context, IPS has emerged as a reliable and up-to-date raw material supplier for supplements, offering an innovative solution to overcome this problem.

The key to the success of IPS microcapsules lies in their gastroresistance, allowing the active ingredient to be delivered directly to the point of maximum effectiveness, namely the intestine. The microcapsules are protected by a gastroresistant gelatin membrane that allows the active substance to pass through the gastric tract without irritating the mucosa, thus contributing to the reduction of side effects typical of the active principle as it is.

The microcapsules developed by IPS through microencapsulation by coacervation, contain between 80 and 90% peppermint oil, with menthol content ranging from 30-55% and mentone from 14-32%. This innovative formulation overcomes the problem of gastric irritation while ensuring maximized effectiveness due to high concentrations of the active ingredient.

IPS proves to be an ideal supplier of microencapsulated raw materials for companies interested in the production of peppermint-based food supplements and nutraceuticals. Their dedication to scientific advancement and the quality of their products allows them to meet the growing needs of an ever-evolving market. Thanks to IPS microcapsules, it is possible to fully exploit the therapeutic potential of peppermint, thereby improving the health and well-being of consumers.